Vascular action of circulating and local natriuretic peptide systems is potentiated in obese/hyperglycemic and hypertensive rats

Endocrinology

Volumn 137, Issue 12, 1996, Pages 5552-5557

  Yoshimoto, Takanobu ^a,b   Naruse, Mitsuhide ^a   Naruse, Kiyoko ^a   Arai, Keiko ^a   Imaki, Toshihiro ^a   Tanabe, Akiyo ^a   Seki, Toshirou ^a   Hirose, Shigehisa ^c   Muraki, Takamura ^b   Demura, Hiroshi ^a  

^a Tokyo Women's Medical University   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR RECEPTOR; CYCLIC GMP; HORMONE RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; HS 142 1; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE C; RECEPTOR SUBTYPE; RIBONUCLEASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME ASSAY; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; HYPERTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; MALE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RECEPTOR UPREGULATION; RNA ANALYSIS; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; TISSUE LEVEL; URINE VOLUME;

EID: 8044248428     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.12.8940383     Document Type: Article

References (38)

1. Rosenzweig A, Seidman CE 1991 Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem 60:229-255
2. Maack T 1992 Receptors of atrial natriuretic factor. Annu Rev Physiol 54:11-27
3. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H 1992 Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β. J Clin Invest 90:1145-1149
4. Inagami T, Naruse M, Hoover R 1995 Endothelium as an endocrine organ. Annu Rev Physiol 57:171-189
5. Chinkers M, Garbers DL, Chang MS, Lowe DG, Chin H, Goeddel DV, Schulz S 1989 A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338:78-83
6. Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, Garbers DL 1989 The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 58:1155-1162
7. Maack T, Suzuki M, Almedia FA, Nussenzveig D, Scarborough RM, McEnroe GA, Lewicki JA 1987 Physiological role of silent receptors of atrial natriuretic factor. Science 238:675-678
8. Suga S, Nakao K, Kishimoto I, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inoue K, Imura H 1992 Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130:229-239
9. Laragh JH 1985 Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolytes homeostasis. N Engl J Med 313:1330-1340
10. Levin ER, Frank HJL 1990 Natriuretic peptides inhibit astroglial proliferation: mediation by C receptor. Am J Physiol 261: R453-R457
11. McLay JS, Chatterjee PK, Jardine AG, Hawksworth GM 1995 Atrial natriuretic factor modulates nitric oxide production: an ANF-C receptor-mediated effect. J Hypertens 13:625-630
12. Yoshimoto T, Naruse M, Naruse K, Fujimaki Y, Tanabe A, Muraki T, Itakura M, Hagiwara H, Hirose S, Demura H 1995 Modulation of vascular natriuretic peptide receptor gene expression in hypertensive and obese hyperglycemic rats. Endocrinology 136:2427-2434
13. Yoshimoto T, Naruse M, Naruse K, Shionoya K, Tanaka M, Tanabe A, Hagiwara H, Hirose S, Muraki T, Demura H 1996 Angiotensin II-dependent down-regulation of vascular natriuretic peptide receptor gene expression in hypertensive rats. Endocrinology 137:1102-1107
14. Ikeda H, Shiono A, Matsuo T, Iwatsuka H, Suzuoki Z 1981 A new genetically obese-hyperglycemic Wistar fatty rat. Diabetes 30:1045-1050
15. Yamakawa T, Tanaka S, Tamura K, Isoda F, Ukawa K, Yamakura Y, Takanashi Y, Kiuchi Y, Umemura S, Ishii M, Sekihara H 1995 Wistar fatty rat is obese and spontaneously hypertensive. Hypertension 25:146-150
16. Morishita Y, Sano T, Ando K, Saitoh Y, Kase H, Yamada K, Matsuda Y 1991 Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor. Biochem Biophys Res Commun 176:949-957
17. Matsuda Y, Morishita Y 1993 HS-142-1: a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. Cardiovasc Drug Rev 11:45-59
18. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
19. Kojima M, Minamino N, Kangawa K, Matsuo H 1990 Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP). FEBS Lett 276:209-213
20. Zeng ZP, Naruse M, Naruse K, Kato Y, Shi YF, Demura H, Shizume K 1991 Antiserum against homologous atrial natriuretic peptide diminishes the natriuretic response during mineralcorticoid escape in rats. Endocrinology 128:226-230
21. Morishita Y, Sano T, Kase H, Yamada K, Inagami T, Matsuda Y 1992 HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist, blocks ANP induced renal responses through a specific interaction with guanylyl cyclase-linked receptors. Eur J Pharmacol 225:203-207
22. Morii N, Nakao K, Kihara M, Sugawara A, Sakamoto M, Yamori Y, Imura H 1986 Decreased content in left atrium and increased plasma concentration of atrial natriuretic polypeptide in spontaneously hypertensive rats (SHR) and SHR stroke-prone. Biochem Biophys Res Commun 135:74-81
23. Kohno M, Horio T, Yoshiyama M, Takeda T 1992 Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles on experimental malignant hypertension. Hypertension 19:206-211
24. Wei CM, Kim CH, Khraibi AA, Miller VM, Bunnet Jr JC 1994 Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro. Hypertension 23:903-907
25. Tremblay J, Huot C, Willenbrock RC, Bayard F, Gossard F, Fujio N, Koch C, Kuchel O, Debinski W, Hamet P 1993 Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats. J Clin Invest 92:2499-2508
26. Suga S, Itoh H, Komatsu Y, Ogawa Y, Kama N, Yoshimasa T, Nakao K 1993 Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells: evidence for CNP as a novel autocrine/paracrine regulation from endothelial cells. Endocrinology 133:3038-3041
27. Brownlee M, Cerami A, Vlassara H 1988 Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321
28. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A 1988 Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodelling. Science 240:1546-1548
29. Ishizaka Y, Kangawa K, Minamino N, Ishii K, Takano S, Eto T, Matsuo H 1992 Isolation and Identification of C-type natriuretic peptide in human monocyte cell line, THP-1. Biochem Biophys Res Commun 189:697-704
30. Hotamisligil GS, Spiegelman BM 1994 Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43:1271-1278
31. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB 1995 The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119
32. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM 1995 Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409-2415
33. Sechi LA, Valentin JP, Griffin CA, Lee E, Bartoli E, Humphreys MH, Schambelan M 1995 Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus. J Clin Invest 95:2451-2457
34. Patel KP, Zhang PL 1989 Reduced renal response to volume expansion in streptozotocin-induced diabetic rats. Am J Physiol 257:R672-R679
35. Patel KP, Zhang PL 1990 Attenuated renal response to atrial natriuretic factor in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol 68:425-430
36. Benigni A, Perico N, Dadan J, Gabanelli M, Galbusera M, Boccardo P, Mennini T, Remuzzi G 1989 Functional implications of decreased renal cortical atrial natriuretic peptide binding in experimental diabetes. Circ Res 66:1453-1460
37. Liebeman JS, Parra L, Newton L, Scandling JD, Loon N, Myers BD 1991 Atrial natriuretic peptide and response to changing plasma volume in diabetic nephropathy. Diabetes 40:893-901
38. Hirata Y, Suzuki Y, Hayakawa H, Suzuki E, Kimura K, Goto A, Kangawa K, Matsuo H, Omata M 1995 Participation of endogenous atrial natriuretic peptide in the regulation of urinary protein excretion in experimental diabetic rats. Clin Sci 88:413-419